| Date Filed | Type | Description |
| 10/03/2023 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on Ryerson Holding Corp|
Txns:
| Granted 300 shares
@ $0 |
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.99, valued at
$99.8k
|
|
| 07/26/2021 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 11/20/2020 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.15, valued at
$206k
|
|
| 05/26/2020 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.52, valued at
$252k
|
|
| 03/24/2020 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.16, valued at
$43.2k
|
|
| 06/17/2019 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 301,908 options to buy
@ $0.6093, valued at
$184k
|
|
| 03/18/2019 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options
@ $5.79, valued at
$115.8k
|
|
| 09/07/2018 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 45,002 shares
@ $0
Granted 52,910 shares
@ $0 |
|
| 11/08/2017 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 50,868 shares
@ $0 |
|
| 04/20/2017 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc. |
| 04/20/2017 |
3
| CALHOUN KIRK K (Director) has filed a Form 3 on PLx Pharma Inc. |
| 06/01/2016 |
3
| CALHOUN KIRK K (Director) has filed a Form 3 on Nant Health, LLC |
| 08/15/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/11/2014 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Granted 33,750 options to buy
@ $0.88, valued at
$29.7k
|
|
| 11/22/2013 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Granted 33,750 options to buy
@ $1.31, valued at
$44.2k
|
|
| 08/01/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/17/2011 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Granted 17,250 options to buy
@ $1.66, valued at
$28.6k
|
|
| 04/14/2011 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Granted 17,250 options to buy
@ $2.25, valued at
$38.8k
|
|
| 12/03/2010 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Granted 11,500 options to buy
@ $2.35, valued at
$27k
|
|
| 10/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/05/2010 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on RESPONSE GENETICS INC|
Txns:
| Exercised options to buy
@ $1.35, valued at
$0 |
|
| 05/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/14/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |